Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
A malignant giant cell tumor of the bone (GCTB) is a rare primary malignant tumor classified as primary or secondary. Wide resection of the primary tumor is recommended for localized malignant GCTB, but the effect of adjuvant chemotherapy is unclear. A systematic review was performed to compare the...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/74267a3d7e8d4412966e9d77119bf92e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:74267a3d7e8d4412966e9d77119bf92e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:74267a3d7e8d4412966e9d77119bf92e2021-11-11T15:30:35ZEffect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review10.3390/cancers132154102072-6694https://doaj.org/article/74267a3d7e8d4412966e9d77119bf92e2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5410https://doaj.org/toc/2072-6694A malignant giant cell tumor of the bone (GCTB) is a rare primary malignant tumor classified as primary or secondary. Wide resection of the primary tumor is recommended for localized malignant GCTB, but the effect of adjuvant chemotherapy is unclear. A systematic review was performed to compare the mortality associated with wide resection with that of wide resection plus adjuvant chemotherapy for primary and secondary localized malignant GCTB. Among the 745 studies identified, 9 were included. A total of 112 cases of localized malignant GCTB were included, with 39 and 73 cases being primary and secondary malignant GCTB. In primary localized malignant GCTB, the mortality rates were 40% (6/15 patients) and 33% (8/24 patients) in the surgery plus adjuvant chemotherapy and surgery-only groups, respectively. Overall pooled odds ratio was 1.07 (95% confidence interval, 0.26–4.37; <i>p</i> = 0.92). In secondary localized malignant GCTB, the mortality rates were 30.6% (11/36 patients) and 62.2% (23/37 patients) in the surgery plus adjuvant chemotherapy and surgery-only groups, respectively. The overall pooled odds ratio was 0.31 (95% confidence interval, 0.10–0.95; <i>p</i> = 0.04). The effect of adjuvant chemotherapy remains unclear for primary localized malignant GCTB, but adjuvant chemotherapy improved the survival of patients with secondary localized malignant GCTB.Rokuro MoriiShinji TsukamotoAlberto RighiKanya HonokiYuu TanakaAkira KidoHiromasa FujiiAndreas F. MavrogenisYasuhito TanakaCostantino ErraniMDPI AGarticlegiant cell tumor of bonelocalizedmalignantadjuvantchemotherapysurgeryNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5410, p 5410 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
giant cell tumor of bone localized malignant adjuvant chemotherapy surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
giant cell tumor of bone localized malignant adjuvant chemotherapy surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Rokuro Morii Shinji Tsukamoto Alberto Righi Kanya Honoki Yuu Tanaka Akira Kido Hiromasa Fujii Andreas F. Mavrogenis Yasuhito Tanaka Costantino Errani Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review |
description |
A malignant giant cell tumor of the bone (GCTB) is a rare primary malignant tumor classified as primary or secondary. Wide resection of the primary tumor is recommended for localized malignant GCTB, but the effect of adjuvant chemotherapy is unclear. A systematic review was performed to compare the mortality associated with wide resection with that of wide resection plus adjuvant chemotherapy for primary and secondary localized malignant GCTB. Among the 745 studies identified, 9 were included. A total of 112 cases of localized malignant GCTB were included, with 39 and 73 cases being primary and secondary malignant GCTB. In primary localized malignant GCTB, the mortality rates were 40% (6/15 patients) and 33% (8/24 patients) in the surgery plus adjuvant chemotherapy and surgery-only groups, respectively. Overall pooled odds ratio was 1.07 (95% confidence interval, 0.26–4.37; <i>p</i> = 0.92). In secondary localized malignant GCTB, the mortality rates were 30.6% (11/36 patients) and 62.2% (23/37 patients) in the surgery plus adjuvant chemotherapy and surgery-only groups, respectively. The overall pooled odds ratio was 0.31 (95% confidence interval, 0.10–0.95; <i>p</i> = 0.04). The effect of adjuvant chemotherapy remains unclear for primary localized malignant GCTB, but adjuvant chemotherapy improved the survival of patients with secondary localized malignant GCTB. |
format |
article |
author |
Rokuro Morii Shinji Tsukamoto Alberto Righi Kanya Honoki Yuu Tanaka Akira Kido Hiromasa Fujii Andreas F. Mavrogenis Yasuhito Tanaka Costantino Errani |
author_facet |
Rokuro Morii Shinji Tsukamoto Alberto Righi Kanya Honoki Yuu Tanaka Akira Kido Hiromasa Fujii Andreas F. Mavrogenis Yasuhito Tanaka Costantino Errani |
author_sort |
Rokuro Morii |
title |
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review |
title_short |
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review |
title_full |
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review |
title_fullStr |
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review |
title_full_unstemmed |
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review |
title_sort |
effect of adjuvant chemotherapy on localized malignant giant cell tumor of bone: a systematic review |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/74267a3d7e8d4412966e9d77119bf92e |
work_keys_str_mv |
AT rokuromorii effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT shinjitsukamoto effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT albertorighi effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT kanyahonoki effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT yuutanaka effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT akirakido effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT hiromasafujii effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT andreasfmavrogenis effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT yasuhitotanaka effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview AT costantinoerrani effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview |
_version_ |
1718435245410222080 |